Electromed (ELMD) Competitors $21.99 +0.32 (+1.48%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$21.91 -0.08 (-0.38%) As of 06:40 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELMD vs. SIBN, BBNX, CBLL, EMBC, AVNS, RXST, BVS, BFLY, KIDS, and SMLRShould you be buying Electromed stock or one of its competitors? The main competitors of Electromed include SiBone (SIBN), Beta Bionics (BBNX), CeriBell (CBLL), Embecta (EMBC), Avanos Medical (AVNS), RxSight (RXST), Bioventus (BVS), Butterfly Network (BFLY), OrthoPediatrics (KIDS), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry. Electromed vs. Its Competitors SiBone Beta Bionics CeriBell Embecta Avanos Medical RxSight Bioventus Butterfly Network OrthoPediatrics Semler Scientific SiBone (NASDAQ:SIBN) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, media sentiment, analyst recommendations, risk, institutional ownership, profitability and earnings. Does the media refer more to SIBN or ELMD? In the previous week, SiBone had 2 more articles in the media than Electromed. MarketBeat recorded 2 mentions for SiBone and 0 mentions for Electromed. SiBone's average media sentiment score of 1.88 beat Electromed's score of 0.00 indicating that SiBone is being referred to more favorably in the media. Company Overall Sentiment SiBone Very Positive Electromed Neutral Do insiders & institutionals hold more shares of SIBN or ELMD? 98.1% of SiBone shares are owned by institutional investors. Comparatively, 40.8% of Electromed shares are owned by institutional investors. 3.9% of SiBone shares are owned by company insiders. Comparatively, 14.0% of Electromed shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts prefer SIBN or ELMD? SiBone presently has a consensus price target of $22.50, indicating a potential upside of 22.08%. Electromed has a consensus price target of $38.00, indicating a potential upside of 72.81%. Given Electromed's stronger consensus rating and higher possible upside, analysts plainly believe Electromed is more favorable than SiBone.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SiBone 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Electromed 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Is SIBN or ELMD more profitable? Electromed has a net margin of 11.34% compared to SiBone's net margin of -15.03%. Electromed's return on equity of 15.71% beat SiBone's return on equity.Company Net Margins Return on Equity Return on Assets SiBone-15.03% -16.00% -11.69% Electromed 11.34%15.71%13.37% Which has more risk and volatility, SIBN or ELMD? SiBone has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500. Comparatively, Electromed has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500. Which has preferable earnings & valuation, SIBN or ELMD? Electromed has lower revenue, but higher earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSiBone$167.18M4.70-$30.91M-$0.64-28.80Electromed$61.44M3.00$5.15M$0.7927.84 SummaryElectromed beats SiBone on 10 of the 17 factors compared between the two stocks. Get Electromed News Delivered to You Automatically Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELMD vs. The Competition Export to ExcelMetricElectromedElectromedical equipment IndustryMedical SectorNYSE ExchangeMarket Cap$184.41M$33.08M$5.45B$20.25BDividend YieldN/AN/A5.35%3.79%P/E Ratio29.323.7226.2527.45Price / Sales3.00194.52412.7735.32Price / Cash41.3641.3625.7817.85Price / Book4.312.347.894.51Net Income$5.15M-$25.54M$3.16B$985.58M7 Day Performance3.48%15.03%2.65%1.40%1 Month Performance8.86%104.85%5.41%3.74%1 Year Performance46.31%114.60%31.79%11.19% Electromed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELMDElectromed1.2082 of 5 stars$21.99+1.5%$38.00+72.8%+46.3%$184.41M$61.44M29.32160High Trading VolumeSIBNSiBone4.1088 of 5 stars$16.52+0.8%$22.50+36.2%+42.5%$704M$176.60M-25.81350Positive NewsBBNXBeta BionicsN/A$15.80-11.7%$23.44+48.4%N/A$685.09M$65.12M0.00294CBLLCeriBell2.7484 of 5 stars$18.49+3.2%$32.50+75.8%N/A$668.23M$65.44M0.00N/APositive NewsEMBCEmbecta4.424 of 5 stars$9.82+0.5%$19.33+96.9%-22.9%$573.88M$1.12B10.912,100AVNSAvanos Medical1.7984 of 5 stars$12.09-0.4%N/A-38.7%$559.09M$689.20M-1.442,227RXSTRxSight2.9742 of 5 stars$13.54-0.5%$37.90+179.9%-78.9%$550.27M$139.93M-20.21220BVSBioventus3.3595 of 5 stars$6.52-0.5%$14.33+119.8%+17.7%$535.58M$567.70M-10.691,200BFLYButterfly Network1.8405 of 5 stars$2.05-1.4%$4.00+95.1%+131.3%$506.94M$82.06M-7.07460KIDSOrthoPediatrics4.3033 of 5 stars$20.59+1.5%$35.83+74.0%-25.7%$500.13M$204.73M-11.77200News CoveragePositive NewsAnalyst UpgradeSMLRSemler Scientific2.3088 of 5 stars$41.99+16.2%$71.00+69.1%+11.9%$468.27M$49.23M-16.09120High Trading Volume Related Companies and Tools Related Companies SIBN Competitors BBNX Competitors CBLL Competitors EMBC Competitors AVNS Competitors RXST Competitors BVS Competitors BFLY Competitors KIDS Competitors SMLR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ELMD) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… And it's all thanks to President Trump. His ...InvestorPlace | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Electromed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
